Ultralife (ULBI) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Ultralife will report Q1 2026 results before the market opens on May 7; analysts expect EPS of $0.15 and revenue of $52.4 million, with an earnings call on May 8 at 8:30 AM ET.
• In its prior quarter (reported Mar 10) Ultralife missed estimates, posting $0.12 EPS versus $0.24 expected and $48.48 million in revenue versus $57.0 million, and recording a negative net margin of 3.09%.
• Shares opened recently at $6.86 with a market cap of $114.3 million, a negative P/E of -19.06, a 52‑week range of $4.36–$9.52, and about 30.7% institutional ownership.

Ultralife (NASDAQ:ULBI - Get Free Report) is projected to announce its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of $0.15 per share and revenue of $52.40 million for the quarter. Investors are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Friday, May 8, 2026 at 8:30 AM ET.

Ultralife (NASDAQ:ULBI - Get Free Report) last announced its earnings results on Tuesday, March 10th. The technology company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.12). The company had revenue of $48.48 million for the quarter, compared to analysts' expectations of $57.00 million. Ultralife had a negative net margin of 3.09% and a positive return on equity of 3.10%.

Ultralife Stock Performance

Shares of NASDAQ:ULBI opened at $6.86 on Friday. The company has a market cap of $114.29 million, a P/E ratio of -19.06 and a beta of 0.74. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.39 and a current ratio of 2.83. Ultralife has a one year low of $4.36 and a one year high of $9.52. The business's 50-day simple moving average is $6.58 and its 200 day simple moving average is $6.30.

Institutional Trading of Ultralife

Several institutional investors have recently added to or reduced their stakes in ULBI. Qube Research & Technologies Ltd bought a new stake in shares of Ultralife in the 2nd quarter valued at approximately $134,000. Heron Bay Capital Management bought a new position in Ultralife during the 4th quarter worth $127,000. Man Group plc bought a new position in Ultralife during the 3rd quarter worth $111,000. Squarepoint Ops LLC bought a new position in shares of Ultralife in the third quarter worth $109,000. Finally, Bank of America Corp DE grew its stake in shares of Ultralife by 39.9% in the third quarter. Bank of America Corp DE now owns 13,351 shares of the technology company's stock worth $91,000 after purchasing an additional 3,810 shares in the last quarter. 30.68% of the stock is owned by institutional investors and hedge funds.

Ultralife Company Profile

Ultralife Corporation NASDAQ: ULBI develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.